Skip to main content
Medical information Clinical review pending

Genetic Testing

LAMC1 Gene Dandy-Walker Malformation and Occipital Cephaloceles LAMC1 Related Genetic Test

Genetic test analyzing the LAMC1 gene to identify mutations associated with Dandy-Walker malformation and occipital cephaloceles. Helps in early diagnosis and management.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (EDTA tube), Extracted DNA, or One drop of blood on an FTA card.
Results
Confirm with the laboratory before booking. Typically 3 to 4 weeks.
Preparation
Confirm with the laboratory before booking. Generally, no special preparation is required for a blood sample.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the LAMC1 Gene Dandy-Walker Malformation and Occipital Cephaloceles LAMC1 Related Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Individuals with suspected Dandy-Walker malformation
  • ✓Individuals with suspected occipital cephalocele
  • ✓Family history of Dandy-Walker malformation
  • ✓Family history of occipital cephalocele
  • ✓Developmental delays associated with brain malformations
  • ✓Dysmorphology evaluation
02

In plain language

What this test helps you understand

Identifies mutations in the LAMC1 gene associated with Dandy-Walker malformation and occipital cephaloceles, aiding in diagnosis and management.
The LAMC1 Gene Dandy-Walker Malformation and Occipital Cephaloceles NGS Genetic DNA Test is a diagnostic tool used to identify genetic mutations linked to Dandy-Walker malformation and occipital cephaloceles. These are conditions affecting brain development and structure, often presenting as types of dysmorphology. Early detection through genetic testing can be important for understanding potential health challenges and planning appropriate management.

This test specifically examines the LAMC1 gene for variations that may contribute to these conditions. We use Next-Generation Sequencing (NGS) technology for a detailed analysis of genetic variations.

Families with a history of Dandy-Walker malformation or occipital cephaloceles, or individuals presenting with related symptoms, may benefit from this test. Symptoms can include unusual head shape or size, developmental delays, or neurological issues. Discussing the test with a healthcare provider or genetic counselor is recommended.

Understanding the results can provide valuable information for medical management, family planning, and potential interventions. A genetic counselor can help interpret the findings and discuss their implications.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm with the laboratory before booking. Generally, no special preparation is required for a blood sample.
SampleBlood sample (EDTA tube), Extracted DNA, or One drop of blood on an FTA card.
MethodologyNext-Generation Sequencing (NGS) analysis of the LAMC1 gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test specifically analyzes the LAMC1 gene. It may not detect mutations in other genes associated with similar conditions. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

These are congenital conditions affecting the structure and development of the brain, specifically the cerebellum and the back of the skull.
Individuals with symptoms or a family history of these conditions should discuss testing with their doctor or a genetic counselor.
The test analyzes a sample of your blood or DNA to look for specific genetic changes in the LAMC1 gene.
Results will be provided by the laboratory, and a genetic counselor can help explain the findings and their implications for you and your family.
Yes, genetic counseling is highly recommended before and after testing to understand the test's purpose, potential results, and implications.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp